MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04998cam a2200613 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
ocn839677985 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20221128212241.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
|---|
| fixed length control field |
m d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr ||||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
120809s2012 nyu o 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2020676506 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
9781619427549 |
| Qualifying information |
(ebook) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
1619427540 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781619427419 |
| Qualifying information |
(hardcover) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
1619427419 |
| Qualifying information |
(hardcover) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
564942 |
| -- |
(N$T) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)839677985 |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
010000 |
| Source |
bisacsh |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
MAIN |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Gene therapy for cardiovascular diseases and arrhythmia |
| Statement of responsibility, etc |
|
| Medium |
[E-Book] |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
New York : |
| Name of producer, publisher, distributor, manufacturer |
Nova Biomedical, |
| Date of production, publication, distribution, manufacture, or copyright notice |
[2012] |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Physical description |
1 online resource. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 490 1# - SERIES TITLE |
|---|
| Series statement |
Cardiology research and clinical developments |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Includes index. |
| 505 0# - CONTENTS |
|---|
| Contents |
GENE THERAPY FOR CARDIOVASCULAR DISEASES AND ARRHYTHMIA; GENE THERAPY FOR CARDIOVASCULAR DISEASES AND ARRHYTHMIA; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Introduction; Chapter I: General Principles of Gene Transfer; 1.1. Viral and Non-viral Gene Delivery; 1.2. Adenovirus; 1.3. Adeno-Associated Virus (AAV); 1.4. Retroviruses; 1.5. Lentivirus; 1.6. Naked DNA; References; Chapter II: Gene Delivery Techniques; 2.1. Current Cardiac Gene Delivery Techniques; 2.2. Direct Gene Delivery; 2.3. Intracoronary Infusion; References. |
| 505 8# - CONTENTS |
|---|
| Contents |
Chapter III: Gene Therapy for Coronary Artery and IschemicHeart Disease3.1. Coronary Artery and Ischemic Heart Disease; 3.2. Gene Therapy for Coronary Atherosclerosis; 3.3. Gene Therapy for Angiogenesis in Ischemia; 3.4. Gene Therapy for Myocardial Reperfusion Injury; References; Chapter IV: Gene Therapy for Heart Failure; References; Chapter V: Viral Gene Therapy in Myocarditis; 5.1. Myocarditis, at the Bedside; 5.2. Myocarditis, at the Bench; 5.2.1. Experimental Animal Models and Pathophysiology; 5.2.2. Experimental Viral Myocarditis; 5.2.3. Experimental Autoimmune Myocarditis. |
| 505 8# - CONTENTS |
|---|
| Contents |
5.2.4. Virus-Associated Gene Transfer5.3. Study Limitations and Open Questions; References; Chapter VI: Gene Therapy for Atrial Arrhythmia: A Therapeutic Approach for Atrial Fibrillation; References; Chapter VII: Gene Therapy for Ventricular Arrhythmia; References; Chapter VIII: Stem Cell Therapy for Cardiovascular Disease; 8.1. Promises and Limitations of Different Cell Populations; 8.1.1. General Aspects; 8.1.2. Differentiation Potential; 8.1.3. Cell Sources in Detail (for Summary Refer to Table 1); 8.1.3.1. Bone Marrow Mononuclear Cells; 8.1.3.2. Mesenchymal Stem Cells. |
| 505 8# - CONTENTS |
|---|
| Contents |
8.1.3.3. CD133+ Progenitor Cells8.1.3.4. CD34+ Progenitor Cells; 8.1.3.5. Myoblasts; 8.1.3.6. Resident Myocardial Progenitor Cells; 8.1.3.7. Embryonic Stem Cells; 8.1.3.8. Induced Pluripotent Stem Cells; 8.2. Stem Cell Delivery; 8.2.1. Intravenous Administration; 8.2.2. Myocardial Injection; 8.2.3. Intracoronary Delivery; 8.3. Cytokine Therapy; 8.4. Mechanisms of Cell-Based Therapy; 8.4.1. Stem Cell Homing; 8.4.2. Stem Cell Migration within the Myocardium; 8.4.3. Precommitment Versus in Vivo Differentiation; 8.4.4. Transdifferentiation versus Cell Fusion. |
| 505 8# - CONTENTS |
|---|
| Contents |
8.4.5. Paracrine Effects of Stem Cell Therapy8.5. Stem Cell versus Gene Therapy; 8.6. Future Directions of Cardiovascular Cell-Therapy; 8.6.1. Priming of Stem Cells; 8.6.2. Bionanotechnology to Restore Extracellular Matrix; 8.6.3. Tissue Engineering; References; Chapter IX: Gene Transfer for the Development of a Biological Pacemaker; 9.1. Anatomy and Physiology of the Human Pacemaker; 9.1.1. Anatomic Basis of the Pacemaker; 9.1.2. Differences in the Action Potential between Pacemaker and Non-Pacemaker Cells; 9.1.2.1. Ventricular Myocyte (Non-Pacemaker Cell) Action Potentials. |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local note |
Master record variable field(s) change: 050 |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Cardiovascular system |
| General subdivision |
Diseases |
| -- |
Treatment. |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Arrhythmia |
| General subdivision |
Treatment. |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Cardiovascular system |
| General subdivision |
Diseases |
| -- |
Gene therapy. |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Arrhythmia |
| General subdivision |
Gene therapy. |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Gene therapy. |
| 700 1# - ADDED PERSONAL NAME |
|---|
| Added personal author |
Kelemen, Kamilla, |
| Relator term |
author. |
| 700 1# - ADDED PERSONAL NAME |
|---|
| Added personal author |
Schweizer, P. |
| Relator term |
author. |
| 700 1# - ADDED PERSONAL NAME |
|---|
| Added personal author |
Li, Jin, |
| Relator term |
author. |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Cardiology research and clinical developments series. |
| 856 40 - ONLINE RESOURCE |
|---|
| Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=564942">https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=564942</a> |
| Link text |
Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Suppress in OPAC |
Do not Suppress in OPAC |
| 588 ## - SOURCE OF DESCRIPTION NOTE |
|---|
| Source of description note |
Description based on print version record. |
| 938 ## - |
|---|
| -- |
YBP Library Services |
| -- |
YANK |
| -- |
7422944 |
| 938 ## - |
|---|
| -- |
EBSCOhost |
| -- |
EBSC |
| -- |
564942 |
| 938 ## - |
|---|
| -- |
ebrary |
| -- |
EBRY |
| -- |
ebr10687818 |
| 938 ## - |
|---|
| -- |
ProQuest Ebook Central |
| -- |
EBLB |
| -- |
EBL3022161 |
| 994 ## - |
|---|
| -- |
92 |
| -- |
N$T |